UB
SUPN icon

UMB Bank’s Supernus Pharmaceuticals SUPN Stock Holding History

UMB Bank’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6K Sell
507
-73
-13% -$3.51K ﹤0.01% 1611
2026
Q1 		$30K Buy
580
+104
+22% +$5.3K ﹤0.01% 1458
2025
Q4 		$23.7K Buy
476
+13
+3% +$632 ﹤0.01% 1500
2025
Q3 		$22.1K Buy
463
+36
+8% +$1.45K ﹤0.01% 1410
2025
Q2 		$13.5K Buy
427
+24
+6% +$769 ﹤0.01% 1500
2025
Q1 		$13.2K Buy
403
+15
+4% +$532 ﹤0.01% 1454
2024
Q4 		$14K Hold
388
– – ﹤0.01% 1375
2024
Q3 		$12.1K Buy
388
+59
+18% +$1.84K ﹤0.01% 1412
2024
Q2 		$8.8K Buy
329
+17
+5% +$493 ﹤0.01% 1291
2024
Q1 		$10.6K Buy
312
+26
+9% +$774 ﹤0.01% 1271
2023
Q4 		$8.28K Sell
286
-127
-31% -$3.37K ﹤0.01% 1336
2023
Q3 		$11.4K Hold
413
– – ﹤0.01% 1257
2023
Q2 		$12.4K Hold
413
– – ﹤0.01% 1242
2023
Q1 		$15K Hold
413
– – ﹤0.01% 1174
2022
Q4 		$15K Sell
413
-86
-17% -$2.99K ﹤0.01% 1195
2022
Q3 		$17K Sell
499
-519
-51% -$16.9K ﹤0.01% 1163
2022
Q2 		$30K Buy
1,018
+45
+5% +$1.29K ﹤0.01% 1045
2022
Q1 		$31K Hold
973
– – ﹤0.01% 1103
2021
Q4 		$29K Buy
+973
New +$29.5K ﹤0.01% 1161
2017
Q2 		– Sell
-19,000
Closed -$595K – 337
2017
Q1 		$595K Hold
19,000
– – 0.02% 225
2016
Q4 		$480K Hold
19,000
– – 0.02% 234
2016
Q3 		$470K Hold
19,000
– – 0.02% 246
2016
Q2 		$387K Hold
19,000
– – 0.02% 258
2016
Q1 		$290K Buy
19,000
+2,200
+13% +$28.7K 0.01% 291
2015
Q4 		$226K Buy
+16,800
New +$260K 0.01% 323

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

UMB Bank's SUPN Position: Q2 2026 in Review

UMB Bank reduced its Supernus Pharmaceuticals (SUPN) stake by 13% in Q2 2026, selling an estimated $3.51K and leaving 507 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

UMB Bank first reported a position in SUPN in Q4 2015 and has held it in 25 quarters since. The position peaked at $595K in Q1 2017. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • UMB Bank held 507 shares of Supernus Pharmaceuticals worth $23.6K as of Q2 2026.
  • UMB Bank sold 73 Supernus Pharmaceuticals shares in Q2 2026, an estimated $3.51K.
  • Supernus Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1611 holding.
  • UMB Bank first reported a position in Supernus Pharmaceuticals in Q4 2015 and has held it in 25 quarters since.
  • UMB Bank's Supernus Pharmaceuticals position peaked at $595K in Q1 2017.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.